2020 annual financial data
Corbus Pharmaceuticals Holdings 2020 Operating cash flow margin
Direct answer
Operating cash flow margin was -2,531.87%.
Operating income was -122,810,233 USD and net income was -111,269,380 USD.
Operating cash flow was -99,685,703 USD.
Get free Corbus Pharmaceuticals Holdings email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 3,937,230 USD
- Operating income
- -122,810,233 USD
- Net income
- -111,269,380 USD
- Operating cash flow
- -99,685,703 USD